Angiogenesis in the human corpus luteum: Changes in expression of angiopoietins in the corpus luteum throughout the menstrual cycle and in early pregnancy

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 11, 2005, Pages 6141-6148

  Sugino, Norihiro ^a   Suzuki, Takashi ^b   Sakata, Aki ^a   Miwa, Ichiro ^a   Asada, Hiromi ^a   Taketani, Toshiaki ^a   Yamagata, Yoshiaki ^a   Tamura, Hiroshi ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CD34 ANTIGEN;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; CORPUS LUTEUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; MENSTRUAL CYCLE; PERICYTE; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; ADULT; ANGIOPOIETIN-1; ANGIOPOIETIN-2; CORPUS LUTEUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; RECEPTOR, TIE-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 27744598168     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-0643     Document Type: Article

References (37)

1. Tamura H, Greenwald GS 1987 Angiogenesis and its hormonal control in the corpus luteum of the pregnant rat. Biol Reprod 36:1149-1154
2. Ferrara N, Chen H, Davis-Smyth T, Geber HP, Nguyen TN, Peers D, Chisholm V, Hillan K, Schwall R 1998 Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 4:336-340
3. Fraser HM, Dickson SE, Lunn SF, Wulff C, Morris KD, Carroll VA, Bicknell R 2000 Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology 141:995-1000
4. Sugino N, Kashida S, Takiguchi S, Karube A, Kato H 2000 Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab 85:3919-3924
5. Kashida S, Sugino N, Takiguchi S, Karube A, Takayama H, Yamagata Y, Nakamura Y, Kato H 2001 Regulation and role of vascular endothelial growth factor in the corpus luteum during mid-pregnancy in rats. Biol Reprod 64:317-323
6. Sugino N, Kashida S, Takiguchi S, Karube-Harada A, Kato H 2001 Expression of vascular endothelial growth factor (VEGF) receptors in rat corpus luteum: regulation by oestradiol during mid-pregnancy. Reproduction 122:875-881
7. Stouffer RL, Martinez-Chequer JC, Molskness TA, Xu F 2001 Regulation and action of angiogenic factors in the primate ovary. Arch Med Res 32:567-575
8. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD 1996 Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180
9. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD 2000 Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6:460-463
10. Maisonpierre PC, Suri C, Jones PC, Jones PF, Bartunkava S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD 1997 Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60
11. Hanahan D 1997 Signaling vascular morphogenesis and maintenance. Science 277:48-50
12. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J 2000 Vascular-specific growth factors and blood vessel formation. Nature 407:242-248
13. Jain RK, Booth MF 2003 What brings pericytes to tumor vessels? J Clin Invest 112:1134-1136
14. Azmi TI, O'Shea JD 1984 Mechanism of deletion of endothelial cells during regression of the corpus luteum. Lab Invest 51:206-217
15. Modlich U, Kaup FJ, Augustin HG 1996 Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Invest 74:771-780
16. Goede V, Schmidt T, Kimmina S, Kozian D, Augustin HG 1998 Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest 78:1385-1394
17. Tanaka J, Acosta TJ, Berisha B, Tetsuka M, Matsui M, Kobayashi S, Schams D, Miyamoto A 2004 Relative changes in mRNA expression of angiopoietins and receptors Tie in bovine corpus luteum during estrous cycle and prostaglandin F2α-induced luteolysis: possible mechanism for the initiation of luteal regression. J Reprod Dev 50:619-626
18. Hazzard TM, Christenson LK, Stouffer RL 2000 Changes in expression of vascular endothelial growth factor and angiopoietin-1 and -2 in the macaque corpus luteum during the menstrual cycle. Mol Hum Reprod 6:993-998
19. Wulff C, Wilson H, Largue P, Duncan WC, Armstrong DG, Fraser HM 2000 Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, Tie-2, and vascular endothelial growth factor messenger ribonucleic acid. J Clin Endocrinol Metab 85:4302-4309
20. Sugino N, Suzuki T, Kashida S, Karube A, Takiguchi S, Kato H 2000 Expression of BCL-2 and Bax in the human corpus luteum during the menstrual cycle and in early pregnancy: regulation by human chorionic gonadotropin. J Clin Endocrinol Metab 85:4379-4386
21. Wulff C, Dickson SE, Duncan WC, Fraser HM 2001 Angiopoietins in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization. Hum Reprod 16:2515-2524
22. Sugino N, Zilberstein M, Srivastava RK, Telleria CM, Nelson SE, Risk M, Chou JY, Gibori G 1998 Establishment and characterization of a simian virus 40-transformed temperature-sensitive rat luteal cell line. Endocrinology 139:1936-1942
23. Hirchenhain J, Huse I, Hess A, Bielfeld P, De Bruyne F, Krussel JS 2003 Differential expression of angiopoietins 1 and 2 and their receptor Tie-2 in human endometrium. Mol Hum Reprod 9:663-669
24. Currie MJ, Gunningham SP, Han C, Scott PAE, Robinson BA, Harris AL, Fox SB 2001 Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling. Clin Cancer Res 7:918-927
25. Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB 1996 Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab 81:353-359
26. Christenson LK, Stouffer RL 1996 Proliferation of microvascular endothelial cells in the primate corpus luteum during the menstrual cycle and simulated early pregnancy. Endocrinology 137:367-374
27. Rodger FE, Young FM, Fraser HM, Illingworth PJ 1997 Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotropin rescue, in the human corpus luteum. Hum Reprod 12:1723-1729
28. Suzuki T, Sasano H, Takaya R, Fukaya T, Yajima A, Nagura H 1998 Cyclic changes of vasculature and vascular phenotypes in normal human ovaries. Hum Reprod 13:953-959
29. Young FM, Rodger FE, Illingworth PJ, Fraser HM 2000 Cell proliferation and vascular morphology in the marmoset corpus luteum. Hum Reprod 15:557-566
30. Sakata A, Taketani T, Yamagata Y, Sugino N, Changes and regulation of blood vessel stability in rat corpus luteum during pregnancy. Proc 37th Annual Meeting of the Society for the Study of Reproduction, Vancouver, Canada, 2004, p 136 (Abstract 190)
31. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD 1998 Increased vascularization in mice overexpressing angiopoietin-1. Science 282:468-471
32. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, Mc-Donald DM 1999 Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286:2511-2514
33. Sato TN, Tozawa Y, Deutsch U, Buchholz KW, Fujiwara Y, Maguire MG, Gridley T, Wolburg H, Risau W, Qin Y 1995 Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74
34. Zhu WH, Maclntyre A, Nicosia RF 2002 Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model. Am J Pathol 161:823-830
35. Siddiqui AJ, Blombcrg P, Wardell E, Hellgren I, Eskandarpour M, Islam KB, Sylven C 2003 Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium. Biochem Biophys Res Commun 310:1002-1009
36. Yamauchi A, Ito Y, Morikawa M, Kobune M, Huang J, Sasaki K, Takahashi K, Nakamura K, Dehari H, Niitsu Y, Abe T, Hamada H 2003 Preadministration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model. J Gene Med 5:994-1004
37. Thurston G 2002 Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J Anat 200:575-580